Literature DB >> 15036033

Plasmodium falciparum and the permeation pathway of the host red blood cell.

Serge L Y Thomas1, Virgilio L Lew.   

Abstract

Invasion of red blood cells by malaria parasites leads to a huge increase in solute traffic across the membrane of a normally tight cell. Recent electrophysiological investigations strongly support earlier evidence from transport and pharmacological studies that the permeability pathway, which the parasite induces in the host cell membrane, is an anion-selective channel. This article analyzes the evidence and controversies concerning the nature of this channel, surveys the main open questions and suggests directions for future research in this area.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036033     DOI: 10.1016/j.pt.2004.01.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  4 in total

1.  Solute transport via the new permeability pathways in Plasmodium falciparum-infected human red blood cells is not consistent with a simple single-channel model.

Authors:  Henry M Staines; Stephanie Ashmore; Hannah Felgate; Jessica Moore; Trevor Powell; J Clive Ellory
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

2.  Febrile temperature leads to significant stiffening of Plasmodium falciparum parasitized erythrocytes.

Authors:  Marina Marinkovic; Monica Diez-Silva; Ivan Pantic; Jeffrey J Fredberg; Subra Suresh; James P Butler
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

Review 3.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.

Authors:  Isabelle Coppens
Journal:  Nat Rev Microbiol       Date:  2013-10-28       Impact factor: 60.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.